Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
non-Hodgkins lymphoma: Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Hodgkin lymphoma based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 454 | 227 | 227 |
Unadjusted prevalence (%) | 0.17 | 0.15 | 0.20 |
Mean age at first event (years) | 46.84 | 41.33 | 52.35 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.10 | 7.34 [3.74, 14.39] | 6.4e-9 | 75 |
15 years | 0.05 | 7.90 [4.00, 15.59] | 2.6e-9 | 68 |
5 years | 0.02 | 15.04 [8.56, 26.40] | 3.9e-21 | 38 |
1 year | - | - | - | - |
Index endpoint: CD2_HODGKIN_LYMPHOMA – Hodgkin lymphoma
GWS hits: 0
before Hodgkin lymphoma
after Hodgkin lymphoma
Loading survival analyses plot
Loading survival analyses table